New Zealand markets closed

Plus Therapeutics, Inc. (PSTV)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3102+0.0102 (+0.78%)
As of 10:10AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 7.68M
Enterprise value 2.68M
Trailing P/E 0.75
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)25.08
Price/book (mrq)3.76
Enterprise value/revenue 18.19
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.67
52-week change 38.33%
S&P500 52-week change 332.30%
52-week high 32.7800
52-week low 30.9700
50-day moving average 31.5230
200-day moving average 31.8165

Share statistics

Avg vol (3-month) 371.26k
Avg vol (10-day) 3141.29k
Shares outstanding 55.9M
Implied shares outstanding 66.38M
Float 85.75M
% held by insiders 12.27%
% held by institutions 111.56%
Shares short (13 Sept 2024) 452.69k
Short ratio (13 Sept 2024) 41.23
Short % of float (13 Sept 2024) 40.91%
Short % of shares outstanding (13 Sept 2024) 40.89%
Shares short (prior month 15 Aug 2024) 483.45k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 306 Aug 2019
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 301 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin -240.15%
Operating margin (ttm)-289.05%

Management effectiveness

Return on assets (ttm)-69.39%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)5.51M
Revenue per share (ttm)1.19
Quarterly revenue growth (yoy)-31.00%
Gross profit (ttm)N/A
EBITDA -13.47M
Net income avi to common (ttm)-13.23M
Diluted EPS (ttm)-3.0900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.44M
Total cash per share (mrq)1.43
Total debt (mrq)3.43M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.50
Book value per share (mrq)-1.34

Cash flow statement

Operating cash flow (ttm)-9.94M
Levered free cash flow (ttm)-1.1M